cbdMD (YCBD) Change in Account Payables (2019)

cbdMD's (YCBD) quarterly Change in Account Payables came in at $306089.0 in Q3 2019, up 285.38% quarter-over-quarter from $79425.0 in Q2 2019.

cbdMD (YCBD) Change in Account Payables (2019) Analysis & Trends

cbdMD has disclosed Change in Account Payables across 1 years of filings, most recently posting $306089.0 for Q3 2019.

Change in Account Payables for Q3 2019 came in at $306089.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $385514.0 (changed N/A YoY), and the FY2019 annual result was -$7502.0, changed N/A from the prior year.
Change in Account Payables came in at $306089.0 for Q3 2019 at cbdMD, up from $79425.0 in the prior quarter.
In the past five years, Change in Account Payables ranged from a high of $306089.0 in Q3 2019 to a low of $79425.0 in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Account Payables (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	62.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	167.64 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	190,000.00
10	cbdMD	3,884.57	-3.38 Mn	3.00 Mn	-

Download Data